News for Healthier Living

FDA Approval Opens New Chapter in Pancreatic Cancer Treatment

FDA Approval of Rasonque (daraxonrasib), represents a monumental shift in the treatment of pancreas cancer and demonstrates that RAS, one of the most important drivers of pancreatic cancer, can be successfully targeted.

August 27, 2026


September 1 2026

August 31 2026

August 30 2026

August 29 2026

August 28 2026

August 27 2026

August 26 2026

August 25 2026

August 24 2026

August 21 2026

August 20 2026

August 19 2026

August 18 2026